IBDEI0E8 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14224,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,14225,0)
 ;;=E11.21^^61^732^17
 ;;^UTILITY(U,$J,358.3,14225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14225,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,14225,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,14225,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,14226,0)
 ;;=E11.39^^61^732^18
 ;;^UTILITY(U,$J,358.3,14226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14226,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,14226,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,14226,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,14227,0)
 ;;=E11.43^^61^732^15
 ;;^UTILITY(U,$J,358.3,14227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14227,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,14227,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,14227,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,14228,0)
 ;;=E11.59^^61^732^13
 ;;^UTILITY(U,$J,358.3,14228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14228,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,14228,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,14228,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,14229,0)
 ;;=E11.618^^61^732^14
 ;;^UTILITY(U,$J,358.3,14229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14229,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,14229,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,14229,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,14230,0)
 ;;=E11.621^^61^732^16
 ;;^UTILITY(U,$J,358.3,14230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14230,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,14230,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,14230,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,14231,0)
 ;;=E11.622^^61^732^20
 ;;^UTILITY(U,$J,358.3,14231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14231,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,14231,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,14231,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,14232,0)
 ;;=E11.65^^61^732^19
 ;;^UTILITY(U,$J,358.3,14232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14232,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,14232,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,14232,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,14233,0)
 ;;=E11.9^^61^732^21
 ;;^UTILITY(U,$J,358.3,14233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14233,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,14233,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,14233,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,14234,0)
 ;;=E13.9^^61^732^22
 ;;^UTILITY(U,$J,358.3,14234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14234,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,14234,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,14234,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,14235,0)
 ;;=E16.2^^61^732^29
 ;;^UTILITY(U,$J,358.3,14235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14235,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,14235,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,14235,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,14236,0)
 ;;=E20.0^^61^732^34
 ;;^UTILITY(U,$J,358.3,14236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14236,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,14236,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,14236,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,14237,0)
 ;;=E20.9^^61^732^30
 ;;^UTILITY(U,$J,358.3,14237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14237,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,14237,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,14237,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,14238,0)
 ;;=E23.0^^61^732^31
 ;;^UTILITY(U,$J,358.3,14238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14238,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,14238,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,14238,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,14239,0)
 ;;=E27.1^^61^732^51
 ;;^UTILITY(U,$J,358.3,14239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14239,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,14239,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,14239,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,14240,0)
 ;;=E27.2^^61^732^1
 ;;^UTILITY(U,$J,358.3,14240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14240,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,14240,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,14240,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,14241,0)
 ;;=E27.3^^61^732^23
 ;;^UTILITY(U,$J,358.3,14241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14241,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,14241,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,14241,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,14242,0)
 ;;=E29.1^^61^732^52
 ;;^UTILITY(U,$J,358.3,14242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14242,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,14242,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,14242,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,14243,0)
 ;;=E55.9^^61^732^59
 ;;^UTILITY(U,$J,358.3,14243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14243,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,14243,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,14243,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,14244,0)
 ;;=E66.01^^61^732^38
 ;;^UTILITY(U,$J,358.3,14244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14244,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,14244,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,14244,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,14245,0)
 ;;=E66.8^^61^732^42
 ;;^UTILITY(U,$J,358.3,14245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14245,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,14245,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,14245,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,14246,0)
 ;;=E66.9^^61^732^43
 ;;^UTILITY(U,$J,358.3,14246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14246,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,14246,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,14246,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,14247,0)
 ;;=E74.39^^61^732^35
 ;;^UTILITY(U,$J,358.3,14247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14247,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,14247,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,14247,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,14248,0)
 ;;=E83.30^^61^732^46
 ;;^UTILITY(U,$J,358.3,14248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14248,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,14248,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,14248,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,14249,0)
 ;;=E83.51^^61^732^28
 ;;^UTILITY(U,$J,358.3,14249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14249,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,14249,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,14249,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,14250,0)
 ;;=E83.52^^61^732^26
 ;;^UTILITY(U,$J,358.3,14250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14250,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,14250,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,14250,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,14251,0)
 ;;=E87.5^^61^732^27
 ;;^UTILITY(U,$J,358.3,14251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14251,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,14251,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,14251,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,14252,0)
 ;;=E89.2^^61^732^48
 ;;^UTILITY(U,$J,358.3,14252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14252,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,14252,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,14252,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,14253,0)
 ;;=E89.6^^61^732^47
 ;;^UTILITY(U,$J,358.3,14253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14253,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
